Dr. Henry H. Woo, MD | Manhasset, NY ...

Dr. Henry Woo, MD

Claim this profile

Northwell Health

Studies Benign Prostatic Hyperplasia
Studies Enlarged Prostate
9 reported clinical trials
15 drugs studied

Affiliated Hospitals

Image of trial facility.

Northwell Health

Image of trial facility.

North Shore University Hospital - Northwell

Clinical Trials Henry Woo, MD is currently running

Image of trial facility.

WEB Device

for Brain Aneurysm

A prospective, multicenter, single arm, interventional study. The target patient population for this study are adult subjects with WNBAs of the anterior and posterior intracranial circulation. The primary effectiveness outcome of the study is adequate intracranial aneurysm occlusion on the 1 year angiogram as adjudicated by a core laboratory.

Recruiting

1 award

N/A

3 criteria

Image of trial facility.

Neuroprotective Agents

for Ischemic Stroke

Ischemic stroke is the leading cause of long-term disability in the United States. Endovascular intervention with mechanical thrombectomy has become the standard of care for acute large vessel occlusion (LVO) stroke since multiple clinical trials demonstrated improved long-term clinical outcomes with treatment. However, despite high rates of successful vessel recanalization and thus reperfusion of ischemic brain tissue in current practice, many patients continue to suffer debilitating strokes and poor long-term functional outcome. Pharmacologic neuroprotection could potentially present a means of addressing this mismatch in radiologic vs. clinical outcomes by protecting and salvaging damaged brain tissue. Intra-arterial delivery of a cocktail of neuroprotective therapy at the time of endovascular reperfusion would provide immediate, targeted therapy directly to the damaged brain territory. Hypothermia, minocycline and magnesium can target multiple facets of the complex ischemic injury cascade, and have each demonstrated neuroprotection in multiple preclinical models. This is a phase I trial that aims to demonstrate safety and feasibility of administering cold saline, minocycline, and magnesium sulfate intra-arterially immediately after thrombectomy in stroke interventions.

Recruiting

2 awards

Phase 1

5 criteria

More about Henry Woo, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Henry Woo, MD has experience with

  • XFLO Expander System (Mercury)
  • WAVE Extra Soft Coil
  • FRED™ X™
  • Intensive Medical Management - No CEA
  • Intensive Medical Management - No CAS
  • Carotid Stenting (CAS)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Henry Woo, MD specialize in?

Is Henry Woo, MD currently recruiting for clinical trials?

Are there any treatments that Henry Woo, MD has studied deeply?

What is the best way to schedule an appointment with Henry Woo, MD?

What is the office address of Henry Woo, MD?

Is there any support for travel costs?